S. Scharf

5.3k total citations · 2 hit papers
16 papers, 3.3k citations indexed

About

S. Scharf is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, S. Scharf has authored 16 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Immunology. Recurrent topics in S. Scharf's work include T-cell and B-cell Immunology (4 papers), Autoimmune Bullous Skin Diseases (2 papers) and Molecular Biology Techniques and Applications (2 papers). S. Scharf is often cited by papers focused on T-cell and B-cell Immunology (4 papers), Autoimmune Bullous Skin Diseases (2 papers) and Molecular Biology Techniques and Applications (2 papers). S. Scharf collaborates with scholars based in United States, Poland and Germany. S. Scharf's co-authors include Randall K. Saiki, Glenn T. Horn, Kary B. Mullis, H.A. Erlich, Norman Arnheim, Lawrence Steinman, David M. Ogrydziak, Chaim Brautbar, M J Sheehy and Barbara S. Nepom and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and FEBS Letters.

In The Last Decade

S. Scharf

16 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Specific Enzymatic Amplification of DNA In Vitro: The Polymerase Chain Reaction

1986 2.1k citations Kary B. Mullis, S. Scharf et al. Cold Spring Harbor Symposia on Quantitative Biology profile →
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. 1985.

1992 362 citations Randall K. Saiki, S. Scharf et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Scharf United States	13	1.5k	927	472	403	302	16	3.3k
H. Frank Germany	28	1.1k 0.8×	732 0.8×	267 0.6×	214 0.5×	496 1.6×	57	2.6k
H. Rubin United States	36	2.3k 1.6×	1.1k 1.1×	419 0.9×	251 0.6×	118 0.4×	109	4.7k
G. Eric Blair United Kingdom	35	1.9k 1.3×	1.0k 1.1×	872 1.8×	172 0.4×	135 0.4×	126	4.4k
Brian Salmons Austria	31	1.9k 1.3×	1.5k 1.6×	632 1.3×	173 0.4×	116 0.4×	139	3.6k
Leslie A. Mitchell Canada	33	1.8k 1.2×	433 0.5×	380 0.8×	156 0.4×	148 0.5×	91	3.2k
H.A. Erlich United States	26	2.3k 1.6×	1.8k 1.9×	1.4k 3.0×	188 0.5×	565 1.9×	50	6.3k
Harry Rubin United States	39	1.8k 1.2×	1.3k 1.4×	484 1.0×	130 0.3×	156 0.5×	120	4.8k
Karl S. Matlin United States	31	2.7k 1.9×	656 0.7×	606 1.3×	199 0.5×	149 0.5×	63	5.0k
Ángel Zaballos Spain	37	2.1k 1.4×	442 0.5×	1.6k 3.3×	129 0.3×	224 0.7×	79	5.0k
J. Thomas Buckley Canada	43	2.6k 1.8×	840 0.9×	2.1k 4.5×	380 0.9×	872 2.9×	103	5.4k

Countries citing papers authored by S. Scharf

Since Specialization

Citations

This map shows the geographic impact of S. Scharf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Scharf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Scharf more than expected).

Fields of papers citing papers by S. Scharf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Scharf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Scharf. The network helps show where S. Scharf may publish in the future.

Co-authorship network of co-authors of S. Scharf

This figure shows the co-authorship network connecting the top 25 collaborators of S. Scharf. A scholar is included among the top collaborators of S. Scharf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Scharf. S. Scharf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Scharf, S., et al.. (1994). Monitoring bone marrow transplant engraftment using fluorescent PCR primers for human identity markers. Human Immunology. 40. 55–55. 1 indexed citations

Begovich, A. B., et al.. (1993). Analysis of HLA class II polymorphism using polymerase chain reaction.. PubMed. 117(5). 482–5. 20 indexed citations

Mullis, Kary B., et al.. (1992). Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. 1986.. PubMed. 24. 17–27. 54 indexed citations

Scharf, S., et al.. (1992). Amplification and characterization of the retinoblastoma gene VNTR by PCR.. PubMed. 50(2). 371–81. 13 indexed citations

Saiki, Randall K., S. Scharf, Kary B. Mullis, et al.. (1992). Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. 1985.. PubMed. 24. 476–80. 362 indexed citations breakdown →

Zwollo, Patty, et al.. (1991). Sequencing of HLA-D in responders and nonresponders to short ragweed allergen, Amb a V. Immunogenetics. 33(2). 141–51. 42 indexed citations

Bugawan, Teodorica L., A. B. Begovich, S. Scharf, et al.. (1991). HLA‐DR, DO AND DP TYPING USING PCR AMPLIFICATION AND IMMOBILIZED PROBES. International Journal of Immunogenetics. 18(1-2). 33–55. 161 indexed citations

Sheehy, M J, et al.. (1989). A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.. Journal of Clinical Investigation. 83(3). 830–835. 224 indexed citations

Scharf, S., et al.. (1989). Specific HLA-DQB and HLA-DRB1 alleles confer susceptibility to pemphigus vulgaris.. Proceedings of the National Academy of Sciences. 86(16). 6215–6219. 94 indexed citations

10.

Scharf, S., et al.. (1989). SPECIFIC HLA-DQB AND HLADRB1 ALLELES CONFER SUSCEPTIBILITY TO PEMFIGUS VULGARIS. 86(16). 6215–6219. 1 indexed citations

11.

Scharf, S., A. Friedmann, Chaim Brautbar, et al.. (1988). HLA class II allelic variation and susceptibility to pemphigus vulgaris.. Proceedings of the National Academy of Sciences. 85(10). 3504–3508. 168 indexed citations

12.

Scharf, S., et al.. (1988). New methodology for HLA class II oligonucleotide typing using polymerase chain reaction (PCR) amplification. Human Immunology. 23(2). 143–143. 12 indexed citations

13.

Mullis, Kary B., et al.. (1986). Specific Enzymatic Amplification of DNA In Vitro: The Polymerase Chain Reaction. Cold Spring Harbor Symposia on Quantitative Biology. 51(0). 263–273. 2064 indexed citations breakdown →

14.

Ogrydziak, David M. & S. Scharf. (1982). Alkaline Extracellular Protease Produced by Saccharomycopsis lipolytica CX161-1B. Microbiology. 128(6). 1225–1234. 68 indexed citations

15.

Ogrydziak, David M., Sha-Yen Cheng, & S. Scharf. (1982). Characterization of Saccharomycopsis lipolytica Mutants Producing Lowered Levels of Alkaline Extracellular Protease. Microbiology. 128(10). 2271–2280. 18 indexed citations

16.

Johnston, Richard F., S. Scharf, & Richard S. Criddle. (1977). Reversal of oligomycin inhibition of mitochondrial ATPase by ionophoric compounds. FEBS Letters. 75(1-2). 213–216. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact